LivaNova (LIVN) Free Cash Flow (2015 - 2026)
LivaNova (LIVN) reported Free Cash Flow of $4.8 million for Q1 2026, down 63.91% on a YoY basis from $13.2 million in Q1 2025, and down 90.52% sequentially from $50.2 million in Q4 2025.
LivaNova (LIVN) Free Cash Flow (2015 - 2026) Analysis & Trends
LivaNova (LIVN) has 12 years of Free Cash Flow data on file, last reported at $4.8 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow fell 63.91% year-over-year to $4.8 million; the trailing twelve-month figure through Mar 2026 stood at $164.9 million (up 13.29% YoY), and the FY2025 full-year result was $173.3 million, up 27.48% from the prior year.
- Free Cash Flow eased to $4.8 million in Q1 2026, from $50.2 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $68.3 million in Q4 2024 to a low of -$23.6 million in Q2 2023.
- A 5-year average of $23.4 million and a median of $20.6 million in 2022 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow tumbled 185.13% in 2022 and soared 328.87% in 2023, its largest moves.
- Tracing LIVN's Free Cash Flow over 5 years: stood at $9.6 million in 2022, then soared by 328.87% to $41.0 million in 2023, then surged by 66.43% to $68.3 million in 2024, then dropped by 26.55% to $50.2 million in 2025, then plunged by 90.52% to $4.8 million in 2026.
- Business Quant data shows LIVN's Free Cash Flow at $4.8 million in Q1 2026, $50.2 million in Q4 2025, and $62.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.38 Bn | 176.08 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 129.56 Bn | 126.68 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 47.58 Bn | 43.90 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn | 449.00 Mn |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | 112.00 Mn |
| 8 | Smith & Nephew | 27.05 Bn | 26.48 Bn | - | - |
| 9 | Koninklijke Philips | 25.59 Bn | 22.46 Bn | 2.07 Bn | 305.56 Mn |
| 10 | LivaNova | 4.37 Bn | 3.83 Bn | 243.75 Mn | 4.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.76 Mn |
| Mar 31, 2026 | 4.76 Mn |
| Dec 31, 2025 | 50.16 Mn |
| Dec 31, 2025 | 50.16 Mn |
| Sep 30, 2025 | 62.18 Mn |
| Sep 30, 2025 | 62.18 Mn |
| Jun 30, 2025 | 47.77 Mn |
| Jun 30, 2025 | 47.77 Mn |
| Mar 31, 2025 | 13.18 Mn |
| Mar 31, 2025 | 13.18 Mn |
| Dec 31, 2024 | 68.30 Mn |
| Dec 31, 2024 | 68.30 Mn |
| Sep 30, 2024 | 32.85 Mn |
| Sep 30, 2024 | 32.85 Mn |
| Jun 30, 2024 | 31.20 Mn |
| Jun 30, 2024 | 31.20 Mn |
| Mar 31, 2024 | 3.58 Mn |
| Mar 31, 2024 | 3.58 Mn |
| Dec 31, 2023 | 41.04 Mn |
| Dec 31, 2023 | 41.04 Mn |